A novel patient-derived xenograft model for claudin-low triple-negative breast cancer
Background Triple-negative breast cancer (TNBC) subtypes are clinically aggressive and
cannot be treated with targeted therapeutics commonly used in other breast cancer …
cannot be treated with targeted therapeutics commonly used in other breast cancer …
[HTML][HTML] Panobinostat suppresses the mesenchymal phenotype in a novel claudin-low triple negative patient-derived breast cancer model
MD Matossian, HE Burks, S Elliott, VT Hoang… - …, 2018 - ncbi.nlm.nih.gov
Claudin-low triple negative breast cancer (CL-TNBC) is a clinically aggressive molecular
TNBC subtype characterized by a propensity to metastasize, recur and acquire …
TNBC subtype characterized by a propensity to metastasize, recur and acquire …
[引用][C] Abstract| PDF| Full Text| Order a Reprint| https://doi. org/10.18632/oncoscience. 412
MD Matossian, HE Burks, S Elliott, VT Hoang…